HANK & LIN'S GROUP
The past is prologue and the future is scintillating
- Li, L., Zhao, R., Hong, H., Li, G., Zhang, Y., Luo, Y., Zha, Z., Zhu, J., Qiao, J., Zhu, L. and Kung, H.F., 68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma. Nuclear medicine and biology, 2021.102, pp.87-96.
-
Linlin Li, et al. Glucagon-Like Peptide-1 Receptor–Targeted PET/CT With 68Ga-HBED-CC-Exendin-4 in Localizing Insulinoma.A Head-to-Head Comparison to 68Ga-NOTA-Exendin-4. Clin Nucl Med 2025:50 (1), 38-43
- Zhang, Q., Zhao, X., Lei, P., Kung, H. F., Yang, Z., Zhu, L., Wang, S., Zhu, H., Meng, X., Duan, Y., Sun, L., Pan, J., Ma, R., Hong, H., Zhao, X., Demchuk, A., Smith, E. E., & Wang, Y. (2021). Evaluating [68Ga]Ga-p14-032 as a Novel PET Tracer for Diagnosis Cerebral Amyloid Angiopathy. Frontiers in neurology, 12, 702185. https://doi.org/10.3389/fneur.2021.70218
![Zhang, Q., Zhao, X., Lei, P., Kung, H. F., Yang, Z., Zhu, L., Wang, S., Zhu, H., Meng, X., Duan, Y., Sun, L., Pan, J., Ma, R., Hong, H., Zhao, X., Demchuk, A., Smith, E. E., & Wang, Y. (2021). Evaluating [68Ga]Ga-p14-032 as a Novel PET Tracer for Diagnosis Cerebral Amyloid Angiopathy. Frontiers in neurology, 12, 702185. https://doi.org/10.3389/fneur.2021.702185](https://impro.usercontent.one/appid/oneComWsb/domain/zhulinbnu.com/media/zhulinbnu.com/onewebmedia/i285134164474001026.jpg?etag=%22707d6-636f57b8%22&sourceContentType=&ignoreAspectRatio&resize=1000,1236 "Zhang, Q., Zhao, X., Lei, P., Kung, H. F., Yang, Z., Zhu, L., Wang, S., Zhu, H., Meng, X., Duan, Y., Sun, L., Pan, J., Ma, R., Hong, H., Zhao, X., Demchuk, A., Smith, E. E., & Wang, Y. (2021). Evaluating [68Ga]Ga-p14-032 as a Novel PET Tracer for Diagnosis Cerebral Amyloid Angiopathy. Frontiers in neurology, 12, 702185. https://doi.org/10.3389/fneur.2021.702185")
- Shi S et al.. "[68Ga] Ga-HBED-CC-DiAsp: A new renal function imaging agent." Nuclear Medicine and Biology 82 (2020): 17-24.
- 1.Hank Kung, Seok Choi, Karl Ploessl, Zhihao Zha and Zehui Wu. New 68Ga Glu-Urea-Lys(Ahx)-HBED-CC-bisphosponate as a dual-targeted imaging agent for PSMA and bone metastasis.Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1395
